Photo: Justin Sullivan/Getty Images

CVS Health and Aetna officials next week will have to convince a federal judge in court that their closed merger is legitimate and that the settlement terms negotiated by the Department of Justice are fine and dandy.

Threat level: Judge Richard Leon, who gave the final seal of approval for the AT&T-Time Warner merger, likely can’t tell CVS and Aetna to unscramble their merger completely, said Andrea Agathoklis Murino, a former DOJ antitrust attorney now at the law firm Goodwin Procter. "But he can say the remedy was insufficient."

The details: The deal’s main concession was Aetna agreeing to sell its Medicare drug plans to WellCare.

  • However, that would mostly shift people toward another large player, and it wouldn’t address the antitrust concerns around stacking a health plan, a pharmacy benefit manager and pharmacies under one umbrella.
  • It's a long shot to send everyone back to the drawing board, said Tim Greaney, a former DOJ antitrust attorney who teaches at UC Hastings. But that doesn’t mean the terms of the settlement can’t change.

Go deeper: The problem facing the CVS Health-Aetna merger

Go deeper

Updated 56 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: FDA approves Gilead's remdesivir as a coronavirus treatment How the pandemic might endMany U.S. deaths were avoidable.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.

FBI: Russian hacking group stole data after targeting local governments

FBI Headquarters. Photo: Mark Wilson/Getty Images

Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.

Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.